Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2015 05:31 ET | Source: VECT-HORUS

VECT-HORUS: Two new patents protecting VECTrans(R) technology issued in several major countries

MARSEILLE, France, Nov. 2, 2015 (GLOBE NEWSWIRE) -- VECT-HORUS, a biotechnology company that designs and develops peptide vectors for addressing drugs or imaging agents to the brain and other organs,...
March 19, 2015 06:30 ET | Source: VECT-HORUS

Neurotensin, vectorised by Vect-Horus, is the first drug-candidate in neuroprotective hypothermia

MARSEILLE, France, March 19, 2015 (GLOBE NEWSWIRE) -- VECT-HORUS is a biotechnology company that designs and develops peptide-vectors to facilitate the delivery of drugs or imaging agents, notably in...
January 19, 2015 01:38 ET | Source: VECT-HORUS

VECT-HORUS announces the signing of a scientific collaboration agreement with SANOFI

VECT-HORUS announces the signing of a scientific collaboration agreement with SANOFI in the field of neurodegenerative diseases MARSEILLE, France, Jan. 19, 2015 (GLOBE NEWSWIRE) -- VECT-HORUS, a...
December 15, 2014 01:34 ET | Source: VECT-HORUS

VECT-HORUS: new equity issue of 1.5 MEU to finance the preclinical development of its first vectorized product

MARSEILLE, France, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Vect-Horus, a biotechnology company that designs and develops peptide vectors that facilitate the delivery of drugs or imaging agents, notably in...
October 30, 2014 12:16 ET | Source: VECT-HORUS

VECT-HORUS appoints Dr Jamal Temsamani as Director of Drug Development & Corporate

MARSEILLE, France, Oct. 30, 2014 (GLOBE NEWSWIRE) -- VECT-HORUS, a biotechnology company that designs and develops peptide vectors facilitating the delivery of drugs or imaging agents, notably in the...